Related references
Note: Only part of the references are listed.Haptoglobin genotype - A determinant of cardiovascular complication risk in type 1 diabetes
Tina Costacou et al.
DIABETES (2008)
Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort
Alicia J. Jenkins et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2008)
Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort:: The Cardiovascular Health Study
Curt D. Furberg et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
High-sensitivity C-reactive protein and silent myocardial ischemia in Chinese with type 2 diabetes mellitus
Ming-Chia Hsieh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients
Matthew A. Allison et al.
JOURNAL OF VASCULAR SURGERY (2007)
Physical activity, C-reactive protein levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study
S. Matthijs Boekholdt et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2006)
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress
Wolfgang Koenig et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
The 30-year natural history of type 1 diabetes complications - The Pittsburgh epidemiology of diabetes complications study experience
G Pambianco et al.
DIABETES (2006)
Electrocardiographic left ventricular hypertrophy in type 1 diabetes - Prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study
S Giunti et al.
DIABETES CARE (2005)
Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction
M Suleiman et al.
DIABETES (2005)
Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes:: a 12-year observation study of 462 patients
O Torffvit et al.
DIABETIC MEDICINE (2005)
Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors -: The Ludwigshafen risk and cardiovascular health study
K Winkler et al.
CIRCULATION (2005)
Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up
ES Brilakis et al.
EUROPEAN HEART JOURNAL (2005)
The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study
T Costacou et al.
DIABETOLOGIA (2005)
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
CM Ballantyne et al.
CIRCULATION (2004)
Risk factors for coronary heart disease in type 1 diabetic patients in Europe - The EURODIAB Prospective Complications Study
SS Soedamah-Muthu et al.
DIABETES CARE (2004)
Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes - Wisconsin epidemiologic study of diabetic retinopathy
BEK Klein et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population -: Results from the 14-year follow-up of a large cohort from southern Germany
W Koenig et al.
CIRCULATION (2004)
Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes
A Roguin et al.
DIABETES CARE (2003)
Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes - 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study
TJ Orchard et al.
DIABETES CARE (2003)
Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress
H Noto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
PM Ridker
CIRCULATION (2003)
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The strong heart study
AP Levy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification
HM Colhoun et al.
DIABETES CARE (2002)
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study
DJ Freeman et al.
DIABETES (2002)
A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women
GJ Blake et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages
KLH Carpenter et al.
FEBS LETTERS (2001)
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.
CJ Packard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
J Danesh et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase:: a potential new risk factor for coronary artery disease
MJ Caslake et al.
ATHEROSCLEROSIS (2000)
C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly
TE Strandberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
